Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer

von Huang, Audris, Jayaraman, Lata, Fura, Aberra, Vite, Gregory D., Trainor, George L., Gottardis, Marco M., Spires, Thomas E., Spires, Vanessa M., Rizzo, Cheryl A., Obermeier, Mary T., Elzinga, Paul A., Todderud, Gordon, Fan, Yi, Newitt, John A., Beyer, Sophie M., Zhu, Yongxin, Warrack, Bethanne M., Goodenough, Angela K., Tebben, Andrew J., Doweyko, Arthur M., Gold, David L., Balog, Aaron
Veröffentlicht in ACS Med Chem Lett (2015)